TXG insider buying and SEC filings, explained
10x Genomics, Inc. · CIK 1770787
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Laboratory Analytical Instruments
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$7.3M
Planned sales (10b5-1)
$9.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 22, 2026 | Planned (10b5-1) | Shehnaaz Suliman (Director) sold 5,723 shares at about $81.19 ($465K), marked as a 10b5-1 plan trade. Holdings down 19% to 23,792 shares. | SEC filing Filed Sep 24, 2026 |
| Sep 22, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 25,000 shares at about $81.22 ($2.0M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,050,249 shares. | SEC filing Filed Sep 24, 2026 |
| Sep 9, 2026 | Planned (10b5-1) | Adam Taich (CFO) sold 46,388 shares at about $64.58 ($3.0M), marked as a 10b5-1 plan trade. Holdings down 13% to 316,344 shares. | SEC filing Filed Sep 11, 2026 |
| Sep 3, 2026 | Sale | John R. Stuelpnagel (Director) sold 20,000 shares at about $61.76 ($1.2M). Holdings down 6% to 328,436 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 8, 2026 |
| Aug 26, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 10,486 shares at about $63.70 ($668K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,075,349 shares. | SEC filing Filed Aug 28, 2026 |
| Aug 24, 2026 | Sale | Serge Saxonov (CEO and Director) sold 18,545 shares at about $63.02 ($1.2M). Holdings down 2% to 1,085,835 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 24, 2026 | Sale | Adam Taich (CFO) sold 17,166 shares at about $63.02 ($1.1M). Holdings down 5% to 362,732 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 24, 2026 | Sale | Benjamin J. Hindson (President / COO and Director) sold 13,818 shares at about $63.02 ($871K). Holdings down 3% to 488,182 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 24, 2026 | Planned (10b5-1) | Shehnaaz Suliman (Director) sold 2,207 shares at about $63.65 ($140K), marked as a 10b5-1 plan trade. Holdings down 7% to 29,515 shares. | SEC filing Filed Aug 26, 2026 |
| Aug 13–14, 2026 | Planned (10b5-1) | Sarah A. Teichmann (Director) sold 7,551 shares between Aug 13 and Aug 14 at about $57.25 ($432K), marked as a 10b5-1 plan trade. Holdings down 21% to 28,058 shares. | SEC filing Filed Aug 17, 2026 |
| Aug 11, 2026 | Sale | John R. Stuelpnagel (Director) sold 20,000 shares at about $57.75 ($1.2M). Holdings down 5% to 348,436 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 30,000 shares at about $34.44 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 3% to 1,108,380 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 16, 2026 | Planned (10b5-1) | Shehnaaz Suliman (Director) sold 5,723 shares at about $32.63 ($187K), marked as a 10b5-1 plan trade. Holdings down 15% to 31,722 shares. | SEC filing Filed Jun 18, 2026 |
| May 22–26, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 28,893 shares between May 22 and May 26 at about $24.54 ($709K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,138,380 shares. | SEC filing Filed May 27, 2026 |
| May 22, 2026 | Sale | Benjamin J. Hindson (President / COO and Director) sold 11,595 shares at $24.44 ($283K). Holdings down 2% to 502,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 22, 2026 | Sale | Adam Taich (CFO) sold 15,098 shares at $24.44 ($369K). Holdings down 4% to 379,898 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| Apr 14, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 5,000 shares at about $24.56 ($123K), marked as a 10b5-1 plan trade. Holdings down <1% to 1,167,273 shares. | SEC filing Filed Apr 16, 2026 |
| Mar 23–24, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 15,000 shares between Mar 23 and Mar 24 at about $19.26 ($289K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,172,273 shares. | SEC filing Filed Mar 25, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Serge Saxonov (CEO and Director) sold 16,152 shares at about $22.73 ($367K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,203,667 shares. | SEC filing Filed Mar 4, 2026 |
| Feb 25, 2026 | Planned (10b5-1) | Sarah A. Teichmann (Director) sold 7,579 shares at $19.41 ($147K), marked as a 10b5-1 plan trade. Holdings down 22% to 26,780 shares. | SEC filing Filed Feb 27, 2026 |
| Feb 23, 2026 | Sale | Serge Saxonov (CEO and Director) sold 9,632 shares at $18.58 ($179K). Holdings down 1% to 1,061,924 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23, 2026 | Sale | Adam Taich (CFO) sold 8,968 shares at $18.58 ($167K). Holdings down 3% to 288,417 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23, 2026 | Sale | Benjamin J. Hindson (President / COO and Director) sold 7,826 shares at $18.58 ($145K). Holdings down 2% to 424,779 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Nov 24, 2025 | Sale | Adam Taich (CFO) sold 11,888 shares at $19.00 ($226K). Holdings down 4% to 297,385 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 24, 2025 | Sale | Benjamin J. Hindson (President / COO and Director) sold 8,283 shares at $19.00 ($157K). Holdings down 2% to 432,605 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 24, 2025 | Sale | Serge Saxonov (CEO and Director) sold 13,261 shares at $19.00 ($252K). Holdings down 1% to 1,021,556 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
13 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:05 PM ET 8-K | Executive or director change (Item 5.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TXG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.